Colgate-Palmolive (NYSE:CL) Given New $105.00 Price Target at Stifel Nicolaus

Colgate-Palmolive (NYSE:CL) had its price objective boosted by Stifel Nicolaus from $95.00 to $105.00 in a report published on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other equities analysts have also recently issued reports on the stock. Citigroup boosted their price target on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a buy rating in a research report on Wednesday, July 10th. Royal Bank of Canada increased their target price on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a sector perform rating in a research report on Monday, April 29th. Deutsche Bank Aktiengesellschaft lifted their price target on Colgate-Palmolive from $98.00 to $104.00 and gave the company a buy rating in a research report on Wednesday, July 17th. Wells Fargo & Company increased their price objective on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an equal weight rating in a report on Wednesday, July 10th. Finally, Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an overweight rating in a report on Tuesday, May 28th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of Moderate Buy and an average price target of $98.58.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $96.49 on Monday. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market cap of $79.16 billion, a P/E ratio of 30.53, a P/E/G ratio of 3.49 and a beta of 0.39. The business’s 50 day moving average price is $95.72 and its 200-day moving average price is $89.93. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $99.63.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter in the previous year, the business posted $0.73 earnings per share. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the sale, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in Colgate-Palmolive by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after purchasing an additional 416,853 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after buying an additional 8,933,912 shares in the last quarter. Norges Bank bought a new position in shares of Colgate-Palmolive during the fourth quarter worth $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd grew its stake in Colgate-Palmolive by 4.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after acquiring an additional 278,150 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Colgate-Palmolive by 1.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,426,430 shares of the company’s stock valued at $352,824,000 after acquiring an additional 77,679 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.